Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer. (Q50107038)
Jump to navigation
Jump to search
scientific article published in April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer. |
scientific article published in April 2009 |
Statements
1 reference
Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer. (English)
1 reference
John C Lantis
1 reference
Deva Boone
1 reference
Cindy Gendics
1 reference
George Todd
1 reference
1 April 2009
1 reference
1 reference
22
1 reference
4
1 reference
167-171
1 reference
Identifiers
1 reference